Dasotraline May Help To Improve Binge-Eating Disorder

2708&nbsp
0

Posted on Nov 27, 2018, 12 a.m.

The novel drug dasotraline has been linked with significant improvement in psychological and behavioral outcomes as compared with placebo in adults with binge eating disorder.

317 patients were included in this double blind randomized trial for 12 weeks with either placebo or flexible dosed dasotraline at 4 mg/day, 6 mg/day, and 8 mg/day. Dasotraline is a dual acting norepinephrine and dopamine reuptake inhibitor.